10 biotech predictions for 2021

Advertisement
10 biotech predictions for 2021
Hollis Johnson/Business Insider

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.

Advertisement

Hello,

Happy New Year! Welcome back to Insider Healthcare, your daily dose of news from the Business Insider healthcare team.

I hope you all had a restful end to the year. It seems like the news cycle didn't slow down all that much over the holidays, so let's jump in to the biggest stories to start 2021.

For starters, vaccine rollout has started slower than expected. About 20 million Americans were expected to get vaccinated by the end of the year. That didn't happen, with only a fraction receiving shots by December 31. Even so, Dr. Anthony Fauci on Sunday said he's optimistic the pace could soon pick up.

Advertisement

Also in healthcare news: Biotech investor Brad Loncar shared his 2021 predictions with us, investors are betting big on mental health, and why Alphabet and Amazon are set up to make healthcare deals in 2021.

10 biotech predictions for 2021
Brad Loncar, biotech investor and CEO of Loncar InvestmentsBrad Loncar

Biotech investor Brad Loncar shares 10 predictions for 2021, including a more than 30% drop for gene-editing stocks, a $3 billion acquisition by Vertex, and a new big threat to society

Read the full list of predictions as told to Andrew Dunn here>>

Investors are betting billions of dollars that Silicon Valley can upend mental healthcare in America

  • Among the coronavirus pandemic, large-scale social unrest, and a grueling election cycle, Americans' mental health is taxed at best and crumbling at worst.
  • The grueling circumstances of the past year have led to a boom in demand for mental health services. With most therapists' offices closed, however, much of that activity has been entirely virtual.
  • Mental health startups that provide virtual services, scheduling platforms, or software that allows individual practitioners to accept insurance have all benefited from the pandemic, and have raked in nearly $1.5 billion from VC investors since the start of the year.
  • Many investors told Business Insider that mental health will soon be one of the biggest areas of investment for their firms.

Read the full story from Megan Hernbroth here>>

Advertisement

Here's why investors think Amazon and Alphabet are poised to make big healthcare deals in 2021

Read the full story from Megan Hernbroth here>>

More stories we're reading:

By this point, typically I'm curious how you all are preparing for the annual JPMorgan healthcare conference. Without flights and massively inflated hotel costs ahead of us, how are you preparing? Let me know at lramsey@businessinsider.com. And you can reach the entire team at healthcare@businessinsider.com.

- Lydia

{{}}